Lizor

Lizor

cefprozil

Manufacturer:

Pharos
Concise Prescribing Info
Contents
Cefprozil
Indications/Uses
Upper & lower resp tract infection, otitis media, secondary bacterial infection of acute bronchitis & acute bacterial exacerbation of chronic bronchitis, uncomplicated skin & skin structure.
Dosage/Direction for Use
Adult & childn ≥13 yr URTI 500 mg 24 hrly. Lower resp tract infection 500 mg 12 hrly. Skin & skin structure infection 250 mg 12 hrly or 500 mg 24 hrly. Childn 2-12 yr URTI 7.5 mg/kg 12 hrly. Childn 6 mth-12 yr Otitis media 15 mg/kg 12 hrly. Infection due to β-haemolytic strep to be given for at least 10 days.
Contraindications
Hypersensitivity.
Special Precautions
History of GI disorders especially colitis. Kidney function should be evaluated before & during treatment. Concomitant use w/ diuretics. Prolonged use may cause overgrowth of nonsusceptible microorganism. Discontinuation of treatment in occurence of superinfections. May cause false +ve result of urine glucose test by Fehling's, Benedict's soln & Clinitest tab. Pregnancy & lactation. Childn <6 mth.
Adverse Reactions
Diarrhea, nausea, vomiting, abdominal pain. Elevation of SGOT/SGPT, alkaline phosphatase & serum bilirubin. Hypersensitivity reactions. Elevation of BUN & serum creatinine. Headache, insomia, genital pruritus, vaginitis, dizziness, hyperactivity, superinfection.
Drug Interactions
Aminoglycosides.
MIMS Class
Cephalosporins
ATC Classification
J01DC10 - cefprozil ; Belongs to the class of second-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Lizor dry syr 125 mg/5 mL
Packing/Price
60 mL x 1's (Rp104,500/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in